Liangshan Prefecture carried out the quality and safety inspection of the new crown virus testing agent

On July 22, He Guixiang, Secretary of the Party Group and Director of Liangshan Prefecture Market Supervision Bureau, led a team to the meeting to supervise and inspect the quality and safety of the new crown virus test agent, implement the "leader" project, and implement the provincial drug regulatory bureau on further strengthening the new coronary virus test agent Requirements for quality and safety supervision.

The inspection team carried out supervision and inspection of the new crown virus detection reagents and operating enterprises such as Huili City People's Hospital, Huili City Disease Control Center, and Huili Xinda Pharmacy. In the methods of "listening to reports, checking information, watching the scene", it focused on the inspection of the supplier's business qualifications, testing reagent product qualifications, purchase inspection records, cold chain transportation records, storage temperature monitoring, etc. On -site inspection of inspection equipment, infrastructure, warehouses, personnel equipment, etc., at the same time inspected the quality management of medical equipment medical equipment, and randomly spot -checked a retail pharmacy operating enterprise to fight the purchase, storage, sales and sales of the original inspection and test reagents. The implementation of the epidemic prevention and control work was checked.

He Guixiang pointed out that the regulatory authorities should effectively improve their political standing, implement "strictest supervision" for the new crown virus testing agents, take resolute and powerful measures, strictly implement the main responsibility of enterprises and use units, effectively fulfill the responsibility for local territorial regulatory supervision, strengthen the new crown crown The quality and safety supervision of the product of the virus testing agent, the discovered illegal and illegal acts, seriously investigate and deal with it in accordance with the law, resolutely keep the quality and safety bottom line, consolidate the hard -won regulatory results, and provide a strong guarantee for the prevention and control of the epidemic.

He Guixiang requested that medical institutions should strictly control the quality of new crown virus nucleic acid testing agents, improve the quality management system of medical equipment, strictly review the qualifications and product qualifications of suppliers, and conscientiously perform the purchase inspection record system. In particular The transportation reagent is required, the whole process of cold chain management is required, and the quality management of product procurement, acceptance, cold chain transportation, storage, and use in the process of product procurement, acceptance, cold chain transportation, storage, and use to ensure the quality and safety of the use of new coronary virus nucleic acid test agents. (Mana Zeng Xuemei)

- END -